Xaira Therapeutics Stock
HealthTechLooking to sell Xaira Therapeutics stock or options?
Xaira Therapeutics is the developer of a comprehensive biotechnology firm committed to fulfilling the potential of advanced artificial intelligence instruments. The firm merges solid product creation, the production of biological and clinical data, and the study of artificial intelligence techniques, both translational and fundamental. These are applied to all stages of the drug discovery and development process. This enables Xaira Therapeutics to provide effective therapies and revolutionize the process of drug discovery and development.
Rsquared, Longwood Fund, Foresite Capital, Two Sigma Ventures, WRF Capital, Sequoia Capital, ARCH Venture Partners, F-Prime Capital, Lux Capital, Foresite Labs, Breyer Capital, New Enterprise Associates, Menlo Ventures, Parker Institute for Cancer Immunotherapy, Byers Capital, SV Angel.